logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11058647 B1

PDFFull Text
Date of Patent:
Jul. 13, 2021

Filed:

Jul. 09, 2020

Systems, methods, and kits for diagnostics and treatment of viral respiratory infection

Applicant:

Applied Biology, Inc., Irvine, CA (US);

Inventors:

Ofer A. Goren, Irvine, CA (US);

John McCoy, Irvine, CA (US);

Assignee:

Applied Biology, Inc., Irvine, CA (US);

Attorney:

Buchanan Ingersoll & Rooney PC

Primary Examiner:

Raymond J Henley, III

Int. Cl.
CPC ...
A61K 31/445 (2006.01); A61K 31/335 (2006.01); A61K 31/201 (2006.01); A61K 31/192 (2006.01); A61K 31/12 (2006.01); A61K 31/4427 (2006.01); A61K 31/4164 (2006.01); A61K 31/4152 (2006.01); A61K 31/16 (2006.01); A61K 38/03 (2006.01); A61P 11/00 (2006.01); A61P 31/14 (2006.01); A61K 31/05 (2006.01); A61K 31/4166 (2006.01); A61K 31/473 (2006.01); A61K 31/4439 (2006.01); A61K 31/57 (2006.01); C07K 16/28 (2006.01); A61K 31/4709 (2006.01); A61K 31/277 (2006.01); A61K 31/437 (2006.01); A61K 38/09 (2006.01); C12N 15/113 (2010.01); A61K 33/18 (2006.01); A61K 31/4155 (2006.01); A61K 31/58 (2006.01); A61K 31/337 (2006.01); C07K 14/71 (2006.01); A61K 31/167 (2006.01);
U.S. Cl.
CPC ...
A61K 31/05 (2013.01); A61K 31/167 (2013.01); A61K 31/277 (2013.01); A61K 31/337 (2013.01); A61K 31/4155 (2013.01); A61K 31/4164 (2013.01); A61K 31/4166 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/473 (2013.01); A61K 31/4709 (2013.01); A61K 31/57 (2013.01); A61K 31/58 (2013.01); A61K 33/18 (2013.01); A61K 38/09 (2013.01); A61P 31/14 (2018.01); C07K 14/71 (2013.01); C07K 16/2827 (2013.01); C12N 15/1136 (2013.01); C12N 2310/11 (2013.01);
Abstract

The present disclosure includes methods, systems, kits and compositions for treating, preventing and diagnosing viral infections, specifically SARS-CoV-2 infections, with an anti-androgen and anti-thyroid medication, a thyroid receptor antagonist, a TGF-β inhibitor or a combination thereof. The present disclosure also describes methods and compositions for the treatment of viral respiratory diseases, specifically SARS-CoV-2 infections, including anti-androgens, anti-thyroid medications, thyroid receptor antagonists, TGF-β inhibitors, RXR inhibitors, furin inhibitors or other agents to disrupt the androgen signaling.

Find Patent Forward Citations

Loading…